D2 Pharma Consulting
Chesterfield, US · Delaware LLC
Founders & leadership
DP
Dean P ErhardtNamed on SEC filing
SK
Steven KirchofNamed on SEC filing
RP
Richard PropperNamed on SEC filing
JW
John WagnerNamed on SEC filing
DS
David SuchanekNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.6M disclosed across 1 round · 2022
▶$1.6MraisedJan 2023 · 4 investors · Other Health CareRule 506(b)
▶$1.6MraisedJan 2023 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Dean P ErhardtExecutive Officer, Director
- Steven KirchofDirector
- Richard PropperDirector
- John WagnerDirector
- David SuchanekDirector
- Offering amount
- $3M
- Amount sold
- $1.6M
- Minimum investment
- $100K
- First sale
- Dec 2022
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has D2 Pharma Consulting raised?
- D2 Pharma Consulting has disclosed $1.6M raised across 1 round.
- Where is D2 Pharma Consulting headquartered?
- D2 Pharma Consulting is headquartered in Chesterfield, US.